The Use of Midazolam and Remifentanil During Dialysis Access Procedures

Clinical trial NCT04226443 · COMPLETED

Trial details

NCT number: NCT04226443
Sponsor: Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sedative Adverse Reaction Analgesic Adverse Reaction Midazolam Adverse Reaction Adverse Reaction to Drug Patient Satisfaction Chronic Kidney Diseases Arteriovenous Fistula

Start date: 2012-08-28
Primary completion: 2016-04-15
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.